Table 1. The ten groups within which N-glycan abundances were analyzed in this study.
Number | Group | Size |
---|---|---|
1 | Right-sided CRC vs. left-sided CRC | 18 vs. 17 |
2 | Right-sided CRC vs. left-sided CRC, stage II samples only | 9 vs. 9 |
3 | Right-sided CRC vs. left-sided CRC, stage III samples only | 9 vs. 8 |
4 | Stage II vs. III CRC, all samples | 18 vs. 17 |
5 | Stage II vs. III CRC, right-sided samples only | 9 vs. 9 |
6 | Stage II vs. III CRC, left-sided samples only | 9 vs. 8 |
7 | Healthy colon tissue, right vs. left | 5 vs. 5 |
8 | Right colon, healthy tissue vs. CRC | 5 vs. 18 |
9 | Left colon, healthy tissue vs. CRC | 5 vs. 17 |
10 | Healthy colon tissue vs. CRC, all samples | 10 vs. 35 |
For each group, relative N-glycan abundance was analyzed separately for both neutral and acidic N-glycans. N-glycan abundance was analyzed for the proposed monosaccharide compositions and, separately, for the proposed structural classes of glycans.